[1]Lehmann J. Twenty years afterward historical notes on the discovery of the antituberculosis effect of paraaminosalicylic acid (PAS) and the first clinical trials[J]. Am Rev Respir Dis, 1964, 90:953-956.
[2]Gandhi NR,Nunn P,Dheda K,et al.J. Multidrug-resistant and extensively drug-resistant tuberculosis:a threat to slobal control fo tuberculosis[J].Lancet(London,England),2013,375:1830-1843.
[3]Dye C, Williams BG, Espinal MA, et al. Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis [J]. Science (New York, N.Y.), 2002, 295(5562):2042-2046.
[4]Recommends EMA. Two new tuberculosis treatments[J]. Drug Discov Devel, 22, 2013.
[5]Falzon D, Jaramillo E, Schunemann HJ, et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update [J]. Eur Respir J, 2011, 38(3): 516-528.
[6]Para-aminosalicylic acid[J]. Tuberculosis, 2008, 88(2): 137-138.
[7]Liu P, Derendorf H. Antimicrobial tissue concentrations[J]. Infect Dis Clin North Am, 2003, 17(3): 599-613.
[8]Pentikainen PJ, Wan SH, Azarnoff DL. Bioavailability of aminosalicylic acid and its various salts in humans IV: comparison of four brands of the sodium salt[J]. J Pharm Sci, 1974, 63(9): 1431-1434.
[9]Peloquin CA, Zhu M, Adam RD, et al. Nix, pharmacokinetics of para-aminosalicylic acid granules under four dosing conditions[J]. Ann Pharmacother, 2001, 35(11): 1332-1338.
[10]Hong L, Jiang W, Zheng W, et al. HPLC analysis of para-aminosalicylic acid and its metabolite in plasma, cerebrospinal fluid and brain tissues[J]. J Pharm Biomed Anal, 2011, 54(5): 1101-1109.
[11]Cummins CL, O'Neil WM, Soo EC, et al. Determination of p-aminosalicylic acid and its N-acetylated metabolite in human urine by capillary zone electrophoresis as a measure of in vivo N-acetyltransferase 1 activity[J]. J Chromatogr B Biomed Sci Appl, 1997, 697(1/2): 283-288.
[12]Lianidou ES, Ioannou PC. Simple spectrofluorometric determination of p-aminobenzoic and p-aminosalicylic acids in biological fluids by use of terbium-sensitized luminescence[J]. Clin Chem, 1996, 42(10): 1659-1665.
[13]Gennaro MC, Calvino R, Abrigo C. Ion interaction reagent reversed-phase high-performance liquid chromatography determination of anti-tuberculosis drugs and metabolites in biological fluids[J]. J Chromatogr B Biomed Sci Appl, 2001, 754(2): 477-486.
[14]关欣,徐雅娟,解生旭,等. HPLC 法测定芪丹颗粒剂中黄芪甲苷的含量[J]. 长春中医药大学学报, 2015,31(2): 245-247.
[15]解朝霞, 张孟. 高效液相色谱法测定糖尿康胶囊中葛根素的含量[J]. 长春中医药大学学报, 2013, 29(5): 932-933. |